Skip to main content

S&P 500 —

Nasdaq-100 —

Dow —

Latest edition

Home Depot's soft forecast, Nvidia's outlook, and bank stocks

Home Depot shoppers made fewer trips but spent more each time, and staples outran tech.

Home Depot slides as full-year profit outlook trails Wall Street expectations

Home Depot, the subject of the lead story

Home Depot slid 2.4% on Tuesday, even though its third quarter beat estimates. The home improvement retailer reported sales of $43.398 billion against the $42.791 billion consensus estimate, and adjusted earnings per share of $3.86 against $3.84. The weak spot was the full-year earnings outlook, which the company set below Wall Street expectations. Customers made fewer purchases but spent more each time: comparable transactions declined 0.5%, while the average ticket rose 3%. Operating margin, the share of sales kept as operating profit, narrowed to 12.6% from 12.9%.

Home Depot lost $8.5 billion in market value and closed at $339.01, 13.3% below its 52-week high. It accounts for 0.39% of the value of the 500 largest U.S. companies, so its drop took $10 from $100,000 spread across them by size. The company also named Chief Financial Officer Richard McPhail its next CEO, effective Nov. 23. He will succeed Ted Decker, who returned from a temporary medical leave and will remain board chair.

For readers

What it means for you: A Dow fund lost $1,640 on every $100,000 Tuesday, as the Dow slid 1.6%. Home Depot shares lost $2,450 on the same stake, more than the Dow fund did. The company is now valued at $340 billion. Its drop took little from $100,000 spread across the 500 largest U.S. companies. Most of Tuesday's loss in a broad fund came from other companies. The Fed's October minutes, out today at 2:00 p.m. ET, may show how officials weighed rates, which reach nearly every holding in a broad fund.

The day ahead

Wednesday’s setup

A housing check and the Fed's October minutes open a holiday-shortened stretch that builds to Wednesday, Nov. 25, when the PCE inflation gauge, a GDP revision and durable goods orders all land.

Before open Target earnings. Target reports a day after Home Depot beat third-quarter estimates but gave a full-year profit outlook below Wall Street expectations, and its stock slid. Target shares closed 6.1% below their 52-week high of $169.89. One question is whether Target keeps or changes its own full-year outlook. Another is whether its comments on holiday spending echo the caution in Home Depot's profit forecast.

8:30 a.m. ET New Residential Construction (Building Permits, Housing Starts, and Housing Completions), October. For mortgage borrowers, the line that matters is permits, which show how many homes builders plan to start next. The Census Bureau counted 1,221,000 housing starts in September. With the 10-year Treasury yield, a guide for mortgage rates, at 5.10%, a stronger reading could keep borrowing costs high. A weaker one could add to the case for lower rates, which could also mean lower yields on savings accounts.

2:00 p.m. ET FOMC minutes, October meeting. The minutes show how closely officials agreed on the path of rates at the October meeting, and whether more of them worried about inflation or jobs. The 2-year Treasury yield, which tracks Fed expectations, sits at 4.80% after it fell 3 basis points on Tuesday. Language leaning toward more cuts could lower credit card and savings rates over time; a focus on inflation could keep both higher.

If you own

  • UnitedHealth shares lost $5,420 on every $100,000 held yesterday, and the company lost $20 billion of its $350 billion market value. UnitedHealth accounts for 0.40% of the value of the 500 largest U.S. companies, so its drop took $22 from $100,000 spread across them by size. For direct holders, the question is whether the selling spreads beyond one insurer. Health care funds, down a smaller 1.4% yesterday, are one gauge.

  • Bank stocks and financial funds lost $1,910 on every $100,000 held yesterday, as the financial sector fund slid 1.9%. That was a steeper loss than the $1,030 the same stake gave up in an S&P 500 fund. For bank holders, the question is whether lower short-term yields might squeeze what lenders earn. The 2-year Treasury yield, which fell yesterday, is one gauge.

  • Small-company funds lost $1,430 on $100,000 held yesterday, as the small-company fund (IWM) slid 1.4%. That was a much bigger loss than the $720 the same stake lost in a Nasdaq-100 fund. The selling was wide: only 198 of 1,088 stocks rose. The question is whether borrowing costs weigh harder on smaller firms. The 10-year Treasury yield is one gauge.

Need to know

Top stories

  1. 1

    NVDA · −0.44% Nvidia rallies after hours on quarterly results. Nvidia shares rose 4.8% after hours on Tuesday, having fallen 0.4% in regular trading. The company reported third-quarter revenue of $115.84 billion, with data centers bringing in $107.6 billion. Nvidia said it expects fourth-quarter revenue of $130 billion, plus or minus 3%. Jensen Huang stepped down as CEO before this report; interim CEO Colette Kress said the roadmap is on track. Nvidia accounts for 4.3% of the 500 largest U.S. companies' combined value, so the after-hours move could carry into a broad index fund at the open. Read more

  2. 2

    Consumer staples outrun tech at fastest pace since 2001. Closing prices show the State Street Consumer Staples Select Sector SPDR ETF (XLP) gained 15% from its Oct. 2 close to a record close on Monday. The technology fund (XLK) now sits 18.4% below its Oct. 6 record close. The ratio of staples to tech, which tracks how staples do against tech, climbed 39.5% since Oct. 2. On Tuesday, the staples fund slid 1.2% and the tech fund fell 0.9%. The question is whether money keeps leaving chip makers; Nvidia's results above may give an early read. Read more

  3. 3

    Eli Lilly signs cancer drug deal with Stipple Bio. Eli Lilly said it signed a research and licensing deal on Monday with private biotech Stipple Bio to develop targeted cancer drugs. Under the agreement, Stipple could receive up to $5.9 billion in milestone payments, plus royalties on any sales. Lilly also pays an upfront sum and makes an equity investment; the companies did not disclose the amounts. Separately, Lilly agreed to buy Calytrix Bio for up to $1.5 billion in cash. Milestone payments are tied to research, development and sales goals, so the full sum depends on drugs reaching them. Read more

AI corner

Three changes that matter

  • Topics: Regulation, Chips

    Lumentum gains on proposed U.S. curbs on Chinese data center gear

    Lumentum rose 2.6% on Tuesday after proposed U.S. curbs on Chinese data center equipment, Reuters reported. Executives at Amazon, Alphabet, Meta, Microsoft, Cisco and CoreWeave warned that full compliance could take years. The question is whether the curbs take effect as proposed.

  • Topics: Startups, Markets

    Anthropic reserves part of its IPO for retail investors in amended filing

    Anthropic is offering 825 million shares at $70 to $78 each, with up to 20% set aside for retail investors, its amended S-1 filing shows. Direxion's Jake Behan said Anthropic rising while Nvidia, Broadcom and AMD keep falling could signal a rotation: money leaving those chipmakers for Anthropic.

  • Topics: Deals

    MongoDB buys Firebolt to speed up data for AI agents

    MongoDB said it bought Firebolt Analytics to add real-time analytics for AI agents but did not disclose terms; Firebolt was valued at $1.4 billion in January 2022, TechCrunch reported. MongoDB reports third-quarter results on Dec. 1, which could show whether AI demand is lifting its sales.

How it works

Guidance

Why a company can beat estimates and still see its stock fall. Guidance is a company's own forecast for the months ahead, and share prices often follow it more closely than the quarter just reported. Home Depot reported sales of $43.398 billion, above the $42.791 billion consensus estimate, yet its full-year profit outlook came in below Wall Street expectations. The stock slid 2.4%, and the company lost $8.5 billion in market value. A share price reflects expected future profit, so a softer forecast can outweigh a beat on past results.

WSD Sudoku, Wednesday: Yield Curve, a medium puzzle.

The close

The big picture. Big technology has given back much of the year's gains. The Nasdaq-100 has fallen 4.9% in November on top of 6.7% in October, trimming its yearly gain to 6.9%. That is the flip side of the staples story above. The S&P 500 holds a 7.2% gain this year despite falling 0.9% in October and 3.2% in November. The Dow is the cushion: up 5.6% this year, though its 1.7% October gain has given way to a 2.0% November slide.

On the calendar. The Personal Income and Outlays report, which carries the PCE price index, the Fed's preferred inflation gauge, is due Nov. 25 at 8:30 a.m. ET. Money-market yields tend to track 3-month Treasury bills, which yield 4.33%. A hotter reading could keep that yield up. A cooler one may lower what cash earns.

Not investment advice.

Markets

Markets, Wednesday’s close
MarketLevelChange
S&P 5007,323.63 −0.23%
Nasdaq-10027,116.26 +0.42%
Dow50,198.17 −1.11%
10-Yr yield5.07% −3 bp
Bitcoin (24 hr)$62,530 −2.17%

Rates, sectors and funds on the markets page

At the close

UnitedHealth falls 10.2% and drags health care stocks lower

UnitedHealth lost $36 billion in market value, and health care funds slid 2.2%. The company gave no reason by the close; a statement from it may show what drove the drop. An S&P 500 fund lost $2 per $1,000.

Wednesday’s close

More Breaking News

More stories

All the news

WSD Sudoku

No. 35: Yield Curve

Today’s puzzle is a Medium grid. Solving it reveals what the term means.

Play today’s puzzle

WallStreetDigest, by email

WallStreetDigest explains what moved in the markets, why it moved and what it could mean for a household's money.